These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2140111

  • 21. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
    Verhagen C, De Pauw BE.
    Int J Clin Pharmacol Res; 1987 Jan; 7(6):491-8. PubMed ID: 2964418
    [Abstract] [Full Text] [Related]

  • 26. Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model.
    Pallanza R, Scotti R, Arioli V.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():15-21. PubMed ID: 2965127
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Options and limitations of teicoplanin in febrile granulocytopenic patients.
    De Pauw BE, Novakova IR, Donnelly JP.
    Br J Haematol; 1990 Dec; 76 Suppl 2():1-5. PubMed ID: 2149042
    [Abstract] [Full Text] [Related]

  • 30. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G, Touzé MD, Meignier M, Reynaud A, Baron D.
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Assessment of the interaction between ciprofloxacin and teicoplanin in vitro and in neutropenic patients.
    Lewin CS, Kelsey SM, Paton R, Newland AC, Amyes SG.
    J Antimicrob Chemother; 1990 Oct; 26(4):549-59. PubMed ID: 2147674
    [Abstract] [Full Text] [Related]

  • 34. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP.
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Efficacy and tolerance of teicoplanin in postoperative infections caused by gram-positive microorganisms].
    Alberghina A, Romeo B, Pessione E, Mauri A, Enrichens F, Sciascia C, Olivero G.
    Minerva Chir; 1987 Sep 15; 42(17):1339-45. PubMed ID: 2959879
    [No Abstract] [Full Text] [Related]

  • 38. Teicoplanin in the treatment of gram-positive-bacterial endocarditis.
    Martino P, Venditti M, Micozzi A, Brandimarte C, Gentile G, Santini C, Serra P.
    Antimicrob Agents Chemother; 1989 Aug 15; 33(8):1329-34. PubMed ID: 2529815
    [Abstract] [Full Text] [Related]

  • 39. An open study of teicoplanin in the treatment of gram-positive infections.
    Nathwani D, Reid TM, Gould IM, Golder D, Smith CC, Douglas JG.
    J Chemother; 1991 Oct 15; 3(5):315-20. PubMed ID: 1839742
    [Abstract] [Full Text] [Related]

  • 40. [Clinical study of teicoplanin in the treatment of patients with gram-positive cocci: the Chinese experience].
    He LX, Pan J, Chen SY, Wang AX, Xie CM, Shen ZY.
    Zhonghua Nei Ke Za Zhi; 2005 May 15; 44(5):337-41. PubMed ID: 16009001
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.